Rare diseases
Investigational molecules
Locations
Back to Italy2 209 clinical trials in Rome, Italy across 15 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on the Effects of Efgartigimod Alfa for Patients with Generalized Myasthenia Gravis
ItalyStudy of treatment discontinuation with nilotinib and asciminib in adults with chronic myeloid leukemia to achieve treatment-free remission
ItalyStudy on the Effects of Satralizumab in Children and Adolescents with Duchenne Muscular Dystrophy
ItalyStudy on Axatilimab and Ruxolitinib for Patients with Newly Diagnosed Chronic Graft-Versus-Host Disease
ItalyStudy on the Safety and Effects of Regadenoson and Gadobutrol in Heart Imaging for Children with Cardiovascular Conditions
ItalyStudy on the Effects and Safety of Ladarixin for Adults and Adolescents with Recent Onset Type 1 Diabetes
ItalyStudy of Camizestrant and CDK4/6 Inhibitor for Patients with Advanced Breast Cancer with ESR1 Mutation
ItalyStudy on JDQ443 and Docetaxel for Patients with Advanced KRAS G12C Mutant Non-Small Cell Lung Cancer
ItalyStudy of FNP-223 tablets to slow disease progression in patients with Progressive Supranuclear Palsy (PSP)
ItalyStudy on the Safety and Effectiveness of Paltusotine for Patients with Acromegaly
ItalyStudy on Sotatercept for Treating Pulmonary Hypertension in Adults with Heart Failure
ItalyStudy on Vedolizumab for Patients with Active Ulcerative Colitis
ItalyThe busiest research cities in the country
What the registry says about research in the country
Clinical studies focusing on Idiopathic Pulmonary Fibrosis and COPD, evaluating new therapeutic approaches for improving lung function and reducing disease progression.
Advanced research includes novel antibody treatments and preventive measures for respiratory infections.
Innovative trials targeting metastatic colorectal cancer, gastric cancer, and acute myeloid leukemia, exploring new treatment combinations and targeted therapies.
Studies focus on improving response rates and survival outcomes in various cancer types.
Research into Parkinson's disease and acute ischemic stroke, investigating novel therapeutic approaches and neuroprotective strategies.
Studies aim to improve neurological outcomes and patient quality of life.
Clinical trials examining Immune Thrombocytopenia and Hidradenitis Suppurativa, testing new therapeutic agents for immune-mediated conditions.
Research focuses on improving treatment outcomes in challenging immune disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
